Matches in SemOpenAlex for { <https://semopenalex.org/work/W2256019504> ?p ?o ?g. }
- W2256019504 endingPage "2704" @default.
- W2256019504 startingPage "2696" @default.
- W2256019504 abstract "For a long time, peptides were considered unsuitable for drug development due to their inherently poor pharmacokinetic properties and proteolytic susceptibility. However, this paradigm has changed significantly in the past decade with the approval of numerous antibodies and proteins as drugs. In parallel, research in the field of synthetic molecules that are able to mimic or complement folding patterns exhibited by biopolymers, but are not recognized by proteases, have received considerable attention as well. Such entities were coined foldamers by Professor Gellman in an Account published in this journal in the late 1990s. Oligomers of N-alkylated 3-aminopropionic acid residues have been called β-peptoids due to their structural similarity to β-peptides and peptoids (N-alkylglycines), respectively. Because bona fide foldamer behavior has been demonstrated for both parent architectures, we wondered if the β-peptoids could serve as a successful addition to the known ensemble of peptidomimetic foldamers. When we entered this field, only the seminal description of libraries of β-peptoid dimers and trimers by Hamper et al. had been published a number of years earlier [ J. Org. Chem. 1998 , 63 , 708 ]. Perhaps somewhat naïvely in retrospect, we envisioned that elongation of chain length combined with introduction of bulky α-chiral side chains would deliver folded structures as reported for the α-peptoid counterparts. Initially, we, and others, were unsucessful in obtaining stable secondary structures of β-peptoid oligomers, and instead, these residues were either incorporated in cyclic structures or in combination with other types of residues to give peptidomimetic constructs with heterogeneous backbones. Amphiphilic architectures with various membrane-targeting activities, such as mimics of antimicrobial peptides or cell-penetrating peptides, have thus been particularly successful. Introduction of β-peptoid residues in histone deacetylase inhibitors mimicking nonribosomal cyclotetrapeptides have also been reported. In the present Account, we will sketch the scientific journey that ultimately delivered robustly folded β-peptoid oligomers. Contributions involving biological evaluation of peptidomimetic constructs containing β-peptoid residues, as mentioned above, which were investigated leading up to these recently reported high-resolution helical structures, will thus be discussed. On the basis of the work described in this Account, we envision that β-peptoids will find future utility as peptidomimetics for biomedical investigation containing both heterogeneous and homogeneous backbones. The recent demonstration of control over the secondary structure of a homogeneous β-peptoid backbone now enables structure-based design of scaffolds with predictable display of desired functionalities in three dimensions." @default.
- W2256019504 created "2016-06-24" @default.
- W2256019504 creator A5025034475 @default.
- W2256019504 creator A5035440100 @default.
- W2256019504 creator A5041984050 @default.
- W2256019504 date "2015-07-15" @default.
- W2256019504 modified "2023-10-12" @default.
- W2256019504 title "β-Peptoid Foldamers at Last" @default.
- W2256019504 cites W1964673383 @default.
- W2256019504 cites W1969217480 @default.
- W2256019504 cites W1970798262 @default.
- W2256019504 cites W1981102665 @default.
- W2256019504 cites W1986326797 @default.
- W2256019504 cites W1988402712 @default.
- W2256019504 cites W1989998611 @default.
- W2256019504 cites W1995538240 @default.
- W2256019504 cites W1997152791 @default.
- W2256019504 cites W2001747316 @default.
- W2256019504 cites W2004507988 @default.
- W2256019504 cites W2005533930 @default.
- W2256019504 cites W2006603232 @default.
- W2256019504 cites W2007415752 @default.
- W2256019504 cites W2008539881 @default.
- W2256019504 cites W2021467632 @default.
- W2256019504 cites W2022679163 @default.
- W2256019504 cites W2024616427 @default.
- W2256019504 cites W2032853605 @default.
- W2256019504 cites W2045642095 @default.
- W2256019504 cites W2046019764 @default.
- W2256019504 cites W2050140989 @default.
- W2256019504 cites W2050485122 @default.
- W2256019504 cites W2050895876 @default.
- W2256019504 cites W2054808758 @default.
- W2256019504 cites W2056086790 @default.
- W2256019504 cites W2058289726 @default.
- W2256019504 cites W2064938254 @default.
- W2256019504 cites W2076859770 @default.
- W2256019504 cites W2079335891 @default.
- W2256019504 cites W2079468129 @default.
- W2256019504 cites W2079740287 @default.
- W2256019504 cites W2081306620 @default.
- W2256019504 cites W2085065303 @default.
- W2256019504 cites W2086578831 @default.
- W2256019504 cites W2087043215 @default.
- W2256019504 cites W2087966689 @default.
- W2256019504 cites W2091332750 @default.
- W2256019504 cites W2091442298 @default.
- W2256019504 cites W2094455866 @default.
- W2256019504 cites W2096649736 @default.
- W2256019504 cites W2097108780 @default.
- W2256019504 cites W2100277403 @default.
- W2256019504 cites W2101092227 @default.
- W2256019504 cites W2115792147 @default.
- W2256019504 cites W2123650819 @default.
- W2256019504 cites W2130087627 @default.
- W2256019504 cites W2132321989 @default.
- W2256019504 cites W2144418931 @default.
- W2256019504 cites W2152466791 @default.
- W2256019504 cites W2157469299 @default.
- W2256019504 cites W2161924081 @default.
- W2256019504 cites W2163659523 @default.
- W2256019504 cites W2312751938 @default.
- W2256019504 cites W2312810287 @default.
- W2256019504 cites W2321715016 @default.
- W2256019504 cites W2330861629 @default.
- W2256019504 cites W2332409720 @default.
- W2256019504 cites W2333790767 @default.
- W2256019504 cites W2427180632 @default.
- W2256019504 cites W2474169068 @default.
- W2256019504 cites W2497816615 @default.
- W2256019504 cites W2979053277 @default.
- W2256019504 cites W4234803768 @default.
- W2256019504 cites W4252505159 @default.
- W2256019504 cites W615655970 @default.
- W2256019504 cites W637743980 @default.
- W2256019504 doi "https://doi.org/10.1021/acs.accounts.5b00257" @default.
- W2256019504 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26176689" @default.
- W2256019504 hasPublicationYear "2015" @default.
- W2256019504 type Work @default.
- W2256019504 sameAs 2256019504 @default.
- W2256019504 citedByCount "93" @default.
- W2256019504 countsByYear W22560195042015 @default.
- W2256019504 countsByYear W22560195042016 @default.
- W2256019504 countsByYear W22560195042017 @default.
- W2256019504 countsByYear W22560195042018 @default.
- W2256019504 countsByYear W22560195042019 @default.
- W2256019504 countsByYear W22560195042020 @default.
- W2256019504 countsByYear W22560195042021 @default.
- W2256019504 countsByYear W22560195042022 @default.
- W2256019504 countsByYear W22560195042023 @default.
- W2256019504 crossrefType "journal-article" @default.
- W2256019504 hasAuthorship W2256019504A5025034475 @default.
- W2256019504 hasAuthorship W2256019504A5035440100 @default.
- W2256019504 hasAuthorship W2256019504A5041984050 @default.
- W2256019504 hasBestOaLocation W22560195041 @default.
- W2256019504 hasConcept C119599485 @default.
- W2256019504 hasConcept C124790011 @default.
- W2256019504 hasConcept C127413603 @default.